🚀 New Remote Job Alert!
💼 Position: Technical Product Manager III
🏢 Company: Freenome
🌍 Location: USA
📁 Category: Product Manager
#RemoteJobs #RemoteWork #WorkFromHome #Hiring #JobOpportunity
Apply now: https://www.remoteitjobs.app/job/freenome-technical-product-manager-iii-remote
💼 Position: Technical Product Manager III
🏢 Company: Freenome
🌍 Location: USA
📁 Category: Product Manager
#RemoteJobs #RemoteWork #WorkFromHome #Hiring #JobOpportunity
Apply now: https://www.remoteitjobs.app/job/freenome-technical-product-manager-iii-remote
September 25, 2026 at 12:25 PM
🚀 New Remote Job Alert!
💼 Position: Technical Product Manager III
🏢 Company: Freenome
🌍 Location: USA
📁 Category: Product Manager
#RemoteJobs #RemoteWork #WorkFromHome #Hiring #JobOpportunity
Apply now: https://www.remoteitjobs.app/job/freenome-technical-product-manager-iii-remote
💼 Position: Technical Product Manager III
🏢 Company: Freenome
🌍 Location: USA
📁 Category: Product Manager
#RemoteJobs #RemoteWork #WorkFromHome #Hiring #JobOpportunity
Apply now: https://www.remoteitjobs.app/job/freenome-technical-product-manager-iii-remote
🚀 New Remote Job Alert!
💼 Position: Technical Product Manager III
🏢 Company: Freenome
🌍 Location: USA
📁 Category: Project Management
#RemoteJobs #RemoteWork #WorkFromHome #Hiring #JobOpportunity
Apply now: https://www.remote-work.app/job/freenome-technical-product-manager-iii-remote
💼 Position: Technical Product Manager III
🏢 Company: Freenome
🌍 Location: USA
📁 Category: Project Management
#RemoteJobs #RemoteWork #WorkFromHome #Hiring #JobOpportunity
Apply now: https://www.remote-work.app/job/freenome-technical-product-manager-iii-remote
September 25, 2026 at 12:30 PM
🚀 New Remote Job Alert!
💼 Position: Technical Product Manager III
🏢 Company: Freenome
🌍 Location: USA
📁 Category: Project Management
#RemoteJobs #RemoteWork #WorkFromHome #Hiring #JobOpportunity
Apply now: https://www.remote-work.app/job/freenome-technical-product-manager-iii-remote
💼 Position: Technical Product Manager III
🏢 Company: Freenome
🌍 Location: USA
📁 Category: Project Management
#RemoteJobs #RemoteWork #WorkFromHome #Hiring #JobOpportunity
Apply now: https://www.remote-work.app/job/freenome-technical-product-manager-iii-remote
Freenome and Roche Move to Take Blood-Based Cancer Screening Worldwide
oncodaily.com/industry/fre...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Freenome #Roche
oncodaily.com/industry/fre...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Freenome #Roche
Freenome and Roche Move to Take Blood-Based Cancer Screening Worldwide - OncoDaily
Freenome and Roche Move to Take Blood-Based Cancer Screening Worldwide / biotech, cancer, cancer screening, Freenome, global health, Headlines, healthcare,
oncodaily.com
November 28, 2025 at 10:53 PM
Full list of entities I follow in #LiquidBiopsy #EarlyCancerScreening Grail Bio $GRAL, Singlera, Freenome, Helio Health, Geneoscopy, Exact Sciences $EXAS, Flatiron Health, $CDNA CareDx, $VCYT Veracyte, Bio-Techne $TECH, Tempus AI $TEM, Guardant Health $GH, Biodesix $BDSX, Sophia Genetics $SOPH
Thank you all for following! Keep it up for content around #biotech #NextGenSequecing #SingleCell #SpatialBiology #NextGenProteomics #SynBio #DNAWrite #BlueSci #SciSky #AI #ComputeAcceleration and the occasional meme.
February 10, 2025 at 10:12 AM
Full list of entities I follow in #LiquidBiopsy #EarlyCancerScreening Grail Bio $GRAL, Singlera, Freenome, Helio Health, Geneoscopy, Exact Sciences $EXAS, Flatiron Health, $CDNA CareDx, $VCYT Veracyte, Bio-Techne $TECH, Tempus AI $TEM, Guardant Health $GH, Biodesix $BDSX, Sophia Genetics $SOPH
Abbott acquires Exact Sciences for $23B, and Freenome and Roche news open.substack.com/pub/albertvi...
Abbott acquires Exact Sciences for $23B, and Freenome and Roche news
An update on the Liquid Biopsy, MCED, Cancer Diagnostics landscape
open.substack.com
November 21, 2025 at 1:41 PM
Abbott acquires Exact Sciences for $23B, and Freenome and Roche news open.substack.com/pub/albertvi...
Freenome and NVIDIA Partner to Revolutionize Multi-Cancer Detection Using AI Deep Learning#USA#Brisbane#NVIDIA#cancer_detection#Freenome
Freenome and NVIDIA Partner to Revolutionize Multi-Cancer Detection Using AI Deep Learning
Freenome combines forces with NVIDIA to enhance early cancer detection technology through AI and deep learning, facilitating personalized screening.
third-news.com
January 12, 2026 at 3:30 PM
Freenome and NVIDIA Partner to Revolutionize Multi-Cancer Detection Using AI Deep Learning#USA#Brisbane#NVIDIA#cancer_detection#Freenome
Freenome Announces New CCO Rob Guigley to Advance Cancer Detection Strategy Amid Exact Sciences Deal#USA#Brisbane#Freenome#Exact_Sciences#Rob_Guigley
Freenome Announces New CCO Rob Guigley to Advance Cancer Detection Strategy Amid Exact Sciences Deal
Freenome has appointed Rob Guigley as Chief Commercial Officer to lead its strategy for cancer detection tests following a key agreement with Exact Sciences.
third-news.com
November 10, 2025 at 12:17 PM
Freenome Announces New CCO Rob Guigley to Advance Cancer Detection Strategy Amid Exact Sciences Deal#USA#Brisbane#Freenome#Exact_Sciences#Rob_Guigley
Exact Sciences FQ4'23 long-form post, with the highlights for free, and a strategic positioning for subscribers, including the Guardant Health $GH, Freenome, and Grail Bio. Rhymes with Haystack, linktr.ee/albertvilella
February 22, 2024 at 12:30 PM
Exact Sciences FQ4'23 long-form post, with the highlights for free, and a strategic positioning for subscribers, including the Guardant Health $GH, Freenome, and Grail Bio. Rhymes with Haystack, linktr.ee/albertvilella
Cancer detection firm Freenome to go public via $330 million SPAC deal
Company part of competitive race to spot disease early through blood-based tests
Company part of competitive race to spot disease early through blood-based tests
Cancer detection firm Freenome to go public via $330 million SPAC deal
Freenome, a Bay Area biotech that is part of the increasingly competitive race to accurately detect cancer early through blood-based tests, plans to go public.
www.statnews.com
December 6, 2025 at 7:19 PM
Cancer detection firm Freenome to go public via $330 million SPAC deal
Company part of competitive race to spot disease early through blood-based tests
Company part of competitive race to spot disease early through blood-based tests
New podcast #40: The SpaceX IPO countdown has begun!
Plus, Medline IPO $MDLN this Wednesday, Notion (potential 2026 IPO), Fervo Energy Series E, and Freenome SPAC $PCSC
youtu.be/NIF_JwyNloE
Plus, Medline IPO $MDLN this Wednesday, Notion (potential 2026 IPO), Fervo Energy Series E, and Freenome SPAC $PCSC
youtu.be/NIF_JwyNloE
Prepare to Invest in the SpaceX IPO - Timeline, IPO Access, How to Invest in SpaceX Stock
YouTube video by Access IPOs
youtu.be
December 14, 2025 at 2:04 PM
New podcast #40: The SpaceX IPO countdown has begun!
Plus, Medline IPO $MDLN this Wednesday, Notion (potential 2026 IPO), Fervo Energy Series E, and Freenome SPAC $PCSC
youtu.be/NIF_JwyNloE
Plus, Medline IPO $MDLN this Wednesday, Notion (potential 2026 IPO), Fervo Energy Series E, and Freenome SPAC $PCSC
youtu.be/NIF_JwyNloE
A week after raising $300M, Freenome wins FDA approval, $100M payment and more around colorectal cancer blood test www.bizjournals.com/sanfrancisco...
Freenome went public for $300 million, then scored a huge victory with colorectal cancer test - San Francisco Business Times
This company raised $300M last week. This week, its cancer test was approved.
www.bizjournals.com
July 27, 2026 at 9:56 PM
A week after raising $300M, Freenome wins FDA approval, $100M payment and more around colorectal cancer blood test www.bizjournals.com/sanfrancisco...
🚨 $PCSC
On June 18, 2026, Perceptive Capital Solutions Corp and Freenome Holdings, Inc. jointly issued a press release announcing, among other things, that the Registration Statement on Form S-4 jointly filed by PCSC and Freenome, in connection with the previously-announced business combination a...
On June 18, 2026, Perceptive Capital Solutions Corp and Freenome Holdings, Inc. jointly issued a press release announcing, among other things, that the Registration Statement on Form S-4 jointly filed by PCSC and Freenome, in connection with the previously-announced business combination a...
SEC Filing: PCSC
Click to view the official SEC document.
www.sec.gov
June 18, 2026 at 10:35 PM
🚨 $PCSC
On June 18, 2026, Perceptive Capital Solutions Corp and Freenome Holdings, Inc. jointly issued a press release announcing, among other things, that the Registration Statement on Form S-4 jointly filed by PCSC and Freenome, in connection with the previously-announced business combination a...
On June 18, 2026, Perceptive Capital Solutions Corp and Freenome Holdings, Inc. jointly issued a press release announcing, among other things, that the Registration Statement on Form S-4 jointly filed by PCSC and Freenome, in connection with the previously-announced business combination a...
Caris Detect enters the MCED space
What does it mean for the other players in Early Cancer Detection, like Grail, Guardant Health, Exact/Abbott, Freenome and others
open.substack.com/pub/albertvi...
What does it mean for the other players in Early Cancer Detection, like Grail, Guardant Health, Exact/Abbott, Freenome and others
open.substack.com/pub/albertvi...
Caris Detect enters the MCED space
What does it mean for the other players in Early Cancer Detection, like Grail, Guardant Health, Exact/Abbott, Freenome and others
open.substack.com
July 3, 2026 at 7:48 AM
Caris Detect enters the MCED space
What does it mean for the other players in Early Cancer Detection, like Grail, Guardant Health, Exact/Abbott, Freenome and others
open.substack.com/pub/albertvi...
What does it mean for the other players in Early Cancer Detection, like Grail, Guardant Health, Exact/Abbott, Freenome and others
open.substack.com/pub/albertvi...
Cancer test company Freenome to go public in $330 million SPAC deal - San Francisco Business Times www.bizjournals.com/sanfrancisco...
Peninsula company rides blank check to Wall Street after raising more than $1 billion as a startup - San Francisco Business Times
Freenome will go public via a SPAC merger at $1.14 billion valuation, the latest biotech to test the markets.
www.bizjournals.com
December 8, 2025 at 3:45 PM
Cancer test company Freenome to go public in $330 million SPAC deal - San Francisco Business Times www.bizjournals.com/sanfrancisco...
Freenome has updated the performance metrics for the v2 of their SimpleScreen #CRC assay. But what does it mean for the field of #LiquidBiopsy #NGS #CancerDx ? open.substack.com/pub/albertvi...
Freenome's updated sensitivity values for their SimpleScreen CRC assay
Updated test version achieved significant performance improvement in detecting advanced precancerous lesions, including those with high-grade dysplasia
open.substack.com
July 10, 2026 at 8:49 AM
Freenome has updated the performance metrics for the v2 of their SimpleScreen #CRC assay. But what does it mean for the field of #LiquidBiopsy #NGS #CancerDx ? open.substack.com/pub/albertvi...
Colon Cancer Prevention Project, Colorectal Cancer Alliance, Exact Sciences, FORCE: Facing Our Risk of Cancer Empowered, Freenome, Geneoscopy, Georgia CORE, GH Foundation, @guardanthealth.bsky.social, Nevada Cancer Coalition, Colon Town, @preventcancer.org, & The Gloria Borges WunderGlo Foundation
July 2, 2025 at 10:18 PM
Colon Cancer Prevention Project, Colorectal Cancer Alliance, Exact Sciences, FORCE: Facing Our Risk of Cancer Empowered, Freenome, Geneoscopy, Georgia CORE, GH Foundation, @guardanthealth.bsky.social, Nevada Cancer Coalition, Colon Town, @preventcancer.org, & The Gloria Borges WunderGlo Foundation
Freenome and Roche to expand collaboration to develop and commercialize cancer screening tests outside the U.S.
https://cancerletter.com/drugs-and-targets/20251121_10h/
https://cancerletter.com/drugs-and-targets/20251121_10h/
Freenome and Roche to expand collaboration to develop and commercialize cancer screening tests outside the U.S. - The Cancer Letter
Freenome, an early cancer detection company, and Roche announced a collaboration agreement to commercialize Freenome’s cancer screening technology in international markets. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login […]
cancerletter.com
December 3, 2025 at 2:00 PM
Freenome and Roche to expand collaboration to develop and commercialize cancer screening tests outside the U.S.
https://cancerletter.com/drugs-and-targets/20251121_10h/
https://cancerletter.com/drugs-and-targets/20251121_10h/
Hi I would like to be added as a contributor:
scholar.google.com/citations?us...
scholar.google.com/citations?us...
Li Tai Fang
Freenome - Cited by 1,165 - Bioinformatics - Genomics - NGS - High-throughput sequencing - Omics
scholar.google.com
November 19, 2024 at 11:15 PM
Hi I would like to be added as a contributor:
scholar.google.com/citations?us...
scholar.google.com/citations?us...
🌟 Diagnostics (Liquid Biopsy & Early Cancer Detection, Genomic Diagnostics)
Strongest growth drivers:
Liquid Biopsy & Early Cancer Detection:
Exact Sciences ($EXAS), Guardant Health ($GH), Natera ($NTRA), and smaller emerging companies (e.g., Freenome, Helio Health, Singlera).
Strongest growth drivers:
Liquid Biopsy & Early Cancer Detection:
Exact Sciences ($EXAS), Guardant Health ($GH), Natera ($NTRA), and smaller emerging companies (e.g., Freenome, Helio Health, Singlera).
March 14, 2025 at 6:21 PM
🌟 Diagnostics (Liquid Biopsy & Early Cancer Detection, Genomic Diagnostics)
Strongest growth drivers:
Liquid Biopsy & Early Cancer Detection:
Exact Sciences ($EXAS), Guardant Health ($GH), Natera ($NTRA), and smaller emerging companies (e.g., Freenome, Helio Health, Singlera).
Strongest growth drivers:
Liquid Biopsy & Early Cancer Detection:
Exact Sciences ($EXAS), Guardant Health ($GH), Natera ($NTRA), and smaller emerging companies (e.g., Freenome, Helio Health, Singlera).
The boss is not your friend
This post at the same time Exact Sciences posted a record total 2Q revenue of $811M, compared to $699M for the same period of 2024, while also (likely) boasting about the layoffs as "a multi-year productivity plan targeting $150 million in annual savings by 2026"
This post at the same time Exact Sciences posted a record total 2Q revenue of $811M, compared to $699M for the same period of 2024, while also (likely) boasting about the layoffs as "a multi-year productivity plan targeting $150 million in annual savings by 2026"
August 7, 2025 at 1:09 PM
The boss is not your friend
This post at the same time Exact Sciences posted a record total 2Q revenue of $811M, compared to $699M for the same period of 2024, while also (likely) boasting about the layoffs as "a multi-year productivity plan targeting $150 million in annual savings by 2026"
This post at the same time Exact Sciences posted a record total 2Q revenue of $811M, compared to $699M for the same period of 2024, while also (likely) boasting about the layoffs as "a multi-year productivity plan targeting $150 million in annual savings by 2026"
大腸がん発見の精度アップ...新たなスクリーニング検査方法の可能性【最新研究】
＜大腸内視鏡検査はがん発見には有効だが、患者にとっては負担が大きい部分も...＞
www.newsweekjapan.jp/stories/life...
＜大腸内視鏡検査はがん発見には有効だが、患者にとっては負担が大きい部分も...＞
www.newsweekjapan.jp/stories/life...
大腸がん発見の精度アップ...新たなスクリーニング検査方法の可能性【最新研究】
＜大腸内視鏡検査はがん発見には有効だが、患者にとっては負担が大きい部分も...＞
中高年層を対象に、大腸がんを正確に検出し、がんが存在しない場合には確実に除外できる新しい血液検査（Freenome b...
www.newsweekjapan.jp
February 15, 2025 at 1:05 AM
大腸がん発見の精度アップ...新たなスクリーニング検査方法の可能性【最新研究】
＜大腸内視鏡検査はがん発見には有効だが、患者にとっては負担が大きい部分も...＞
www.newsweekjapan.jp/stories/life...
＜大腸内視鏡検査はがん発見には有効だが、患者にとっては負担が大きい部分も...＞
www.newsweekjapan.jp/stories/life...
Breakthrough ideas happen when our working groups meet in person.
Tyler Hutchinson from Freenome put it best:
“It’s not just the networking—it’s the forward-thinking ideas and the excitement everyone has for where the field is going.”
#LiquidBiopsy #Innovation #Collaboration #BLOODPACQ1meeting
Tyler Hutchinson from Freenome put it best:
“It’s not just the networking—it’s the forward-thinking ideas and the excitement everyone has for where the field is going.”
#LiquidBiopsy #Innovation #Collaboration #BLOODPACQ1meeting
May 22, 2025 at 2:12 PM
Breakthrough ideas happen when our working groups meet in person.
Tyler Hutchinson from Freenome put it best:
“It’s not just the networking—it’s the forward-thinking ideas and the excitement everyone has for where the field is going.”
#LiquidBiopsy #Innovation #Collaboration #BLOODPACQ1meeting
Tyler Hutchinson from Freenome put it best:
“It’s not just the networking—it’s the forward-thinking ideas and the excitement everyone has for where the field is going.”
#LiquidBiopsy #Innovation #Collaboration #BLOODPACQ1meeting
